Sumitomo Dainippon Pharma Performance
| DNPUFDelisted Stock | USD 4.37 0.00 0.00% |
The entity has a beta of -0.15, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sumitomo Dainippon are expected to decrease at a much lower rate. During the bear market, Sumitomo Dainippon is likely to outperform the market. Sumitomo Dainippon Pharma right now has a risk of 0.0%. Please validate Sumitomo Dainippon standard deviation, value at risk, as well as the relationship between the Value At Risk and day median price , to decide if Sumitomo Dainippon will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sumitomo Dainippon Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Sumitomo Dainippon is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 193.7 B | |
| Total Cashflows From Investing Activities | -18.3 B |
Sumitomo |
Sumitomo Dainippon Relative Risk vs. Return Landscape
If you would invest 437.00 in Sumitomo Dainippon Pharma on October 4, 2024 and sell it today you would earn a total of 0.00 from holding Sumitomo Dainippon Pharma or generate 0.0% return on investment over 90 days. Sumitomo Dainippon Pharma is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Sumitomo, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Sumitomo Dainippon Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sumitomo Dainippon's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Sumitomo Dainippon Pharma, and traders can use it to determine the average amount a Sumitomo Dainippon's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DNPUF |
Based on monthly moving average Sumitomo Dainippon is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sumitomo Dainippon by adding Sumitomo Dainippon to a well-diversified portfolio.
Sumitomo Dainippon Fundamentals Growth
Sumitomo Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Sumitomo Dainippon, and Sumitomo Dainippon fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sumitomo Pink Sheet performance.
| Return On Equity | -0.0399 | |||
| Return On Asset | -0.0075 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 2.85 B | |||
| Shares Outstanding | 397.29 M | |||
| Price To Earning | 4.79 X | |||
| Price To Book | 0.64 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 560.03 B | |||
| EBITDA | 124.36 B | |||
| Cash And Equivalents | 265.59 B | |||
| Cash Per Share | 668.50 X | |||
| Total Debt | 243.96 B | |||
| Debt To Equity | 0.36 % | |||
| Book Value Per Share | 1,599 X | |||
| Cash Flow From Operations | 31.24 B | |||
| Earnings Per Share | 0.24 X | |||
| Total Asset | 1.31 T | |||
| Retained Earnings | 349.13 B | |||
| Current Asset | 384.35 B | |||
| Current Liabilities | 159.68 B | |||
About Sumitomo Dainippon Performance
By analyzing Sumitomo Dainippon's fundamental ratios, stakeholders can gain valuable insights into Sumitomo Dainippon's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sumitomo Dainippon has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sumitomo Dainippon has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. Dai Nippon operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 6987 people.Things to note about Sumitomo Dainippon Pharma performance evaluation
Checking the ongoing alerts about Sumitomo Dainippon for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Sumitomo Dainippon Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sumitomo Dainippon is not yet fully synchronised with the market data | |
| Sumitomo Dainippon has a very high chance of going through financial distress in the upcoming years | |
| About 59.0% of the company shares are held by company insiders |
- Analyzing Sumitomo Dainippon's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sumitomo Dainippon's stock is overvalued or undervalued compared to its peers.
- Examining Sumitomo Dainippon's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sumitomo Dainippon's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sumitomo Dainippon's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sumitomo Dainippon's pink sheet. These opinions can provide insight into Sumitomo Dainippon's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Sumitomo Pink Sheet
If you are still planning to invest in Sumitomo Dainippon Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sumitomo Dainippon's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stocks Directory Find actively traded stocks across global markets |